Sanofi Halts Late-Stage Trial of Experimental Drug for Rare Autoimmune Disorder
2026-06-10 13:30:22
Sanofi halted a late-stage trial of an experimental medicine for a rare autoimmune disorder. According to Bloomberg, the move increases pressure on the drugmaker’s new chief executive to strengthen Sanofi’s pipeline.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
